<< The Role Of Biomarkers In Common Pediatric Emergency Department Complaints: An Evidence-Based Approach

Risk Management Pitfalls For Biomarkers

  1. “My patient recently underwent chemotherapy, but I would like to use a biomarker to help facilitate the diagnosis.“
    Studies examining the diagnostic ability of biomarkers nearly always exclude immunocompromised patients. Practitioners should not apply biomarkers to the clinical scenarios discussed in this review if the patient is potentially immunocompromised.

To read the rest of this section, choose one of the options below.

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.